ferumoxytol (Feraheme, ferrosoferric oxide)

From Aaushi
Jump to navigation Jump to search

Indications

Dosage

Injection: 30 mg/mL (elemental iron) solution for injection in 17 mL vials containing 510 mg of elemental iron.

Adverse effects

Mechanism of action

More general terms

References

  1. Prescriber's Letter 16(9): 2009 New Drug: Feraheme (Ferumoxytol) Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=250913&pb=PRL (subscription needed) http://www.prescribersletter.com
  2. Prescriber's Letter 17(2): 2010 New Drugs Approved by the FDA in 2009 Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=260213&pb=PRL (subscription needed) http://www.prescribersletter.com
  3. 3.0 3.1 Klenk C et al Ionising radiation-free whole-body MRI versus 38F-fluorodeoxy- glucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study. The Lancet Oncology, Early Online Publication, 19 February 2014 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24559803 <Internet> http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045%2814%2970021-X/abstract
  4. 4.0 4.1 FDA Drug Safety Communication: March 30, 2015 FDA strengthens warnings and changes prescribing instructions to decrease the risk of serious allergic reactions with anemia drug Feraheme (ferumoxytol). http://www.fda.gov/Drugs/DrugSafety/ucm440138.htm

Database